MedPath

Cefuroxime

CEFUROXIME FOR INJECTION, USP

Approved
Approval ID

19902965-d2d6-433f-982d-0095014df4e8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 27, 2018

Manufacturers
FDA

Hikma Pharmaceuticals USA Inc.

DUNS: 001230762

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cefuroxime

PRODUCT DETAILS

NDC Product Code0143-9568
Application NumberANDA065048
Marketing CategoryC73584
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateSeptember 27, 2018
Generic NameCefuroxime

INGREDIENTS (1)

CEFUROXIME SODIUMActive
Quantity: 750 mg in 1 1
Code: R8A7M9MY61
Classification: ACTIM

Cefuroxime

PRODUCT DETAILS

NDC Product Code0143-9567
Application NumberANDA065048
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateSeptember 27, 2018
Generic NameCefuroxime

INGREDIENTS (1)

CEFUROXIME SODIUMActive
Quantity: 1.5 g in 1 1
Code: R8A7M9MY61
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cefuroxime - FDA Drug Approval Details